A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer-Reference-Cited by-同舟云学术

A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer

Published:2007-10 Issue:4 Volume:12 Page:395-402
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Berns Katrien,Horlings Hugo M.,Hennessy Bryan T.,Madiredjo Mandy,Hijmans E. Marielle,Beelen Karin,Linn Sabine C.,Gonzalez-Angulo Ana Maria,Stemke-Hale Katherine,Hauptmann Michael,Beijersbergen Roderick L.,Mills Gordon B.,van de Vijver Marc J.,Bernards René

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference20 articles.

1. A large-scale RNAi screen in human cells identifies new components of the p53 pathway;Berns;Nature,2004

2. An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors;Brummelkamp;Nat. Chem. Biol.,2006

3. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer;Carpten;Nature,2007

4. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues;Chui;Br. J. Cancer,1996

5. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets;Clynes;Nat. Med.,2000

Cited by 1375 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long road towards effective HER3 targeting in breast cancer;Cancer Treatment Reviews;2024-09

2. Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics;Journal of Chemotherapy;2024-08-05

3. PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer;Cancer Letters;2024-08

4. An ultra-sensitive and rapid immunosensor for the onsite detection of circulating tumor DNA in breast cancer;Frontiers in Bioengineering and Biotechnology;2024-07-12

5. The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer;Cancer Treatment Reviews;2024-07